Kairos Pharma Ltd
KAPA0.915USD
-0.004-0.42%
Market hours （ET）Quotes delayed by 15 min
USD0.000Pre-market (ET)
14.99MMarket Cap
LossP/E TTM
Kairos Pharma Ltd
0.915
-0.004-0.42%
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
Operating cash flows (indirect method)
Cash flow from continuing operating activities
-2083.33%-714.00K
-2831.82%-1.80M
-2319.78%-2.02M
-147.06%-168.00K
550.00%36.00K
195.65%66.00K
275.00%91.00K
19.05%-68.00K
94.59%-8.00K
---69.00K
---52.00K
---84.00K
---148.00K
Net income from continuing operations
-290.71%-1.26M
12.34%-980.00K
-235.58%-1.05M
-7.20%-253.00K
-121.23%-323.00K
-470.41%-1.12M
-33.33%-312.00K
38.70%-236.00K
37.87%-146.00K
---196.00K
---234.00K
---385.00K
---235.00K
Operating gains losses
0.00%40.00K
0.00%40.00K
0.00%40.00K
0.00%40.00K
0.00%40.00K
0.00%40.00K
0.00%40.00K
0.00%40.00K
0.00%40.00K
--40.00K
--40.00K
--40.00K
--40.00K
Other non-cash items
280.00%76.00K
-160.70%-570.00K
1050.00%115.00K
90.00%19.00K
100.00%20.00K
9290.00%939.00K
-88.89%10.00K
-96.00%10.00K
-82.76%10.00K
--10.00K
--90.00K
--250.00K
--58.00K
Change in working capital
44.48%432.00K
-397.56%-610.00K
-581.30%-1.70M
-77.97%26.00K
239.77%299.00K
166.23%205.00K
578.85%353.00K
972.73%118.00K
900.00%88.00K
--77.00K
--52.00K
--11.00K
---11.00K
-Change in prepaid expenses
-54.55%-17.00K
-411.11%-28.00K
-22.22%7.00K
122.22%2.00K
35.29%-11.00K
80.00%9.00K
80.00%9.00K
-325.00%-9.00K
-21.43%-17.00K
--5.00K
--5.00K
--4.00K
---14.00K
-Change in payables and accrued expense
-160.32%-187.00K
33.16%261.00K
-155.52%-191.00K
-81.10%24.00K
195.24%310.00K
172.22%196.00K
631.91%344.00K
1714.29%127.00K
3400.00%105.00K
--72.00K
--47.00K
--7.00K
--3.00K
-Change in other current assets
--636.00K
---843.00K
---1.52M
----
----
----
----
----
----
----
----
----
----
Cash from non-recurring investing activities
Cash from operating activities
-2083.33%-714.00K
-2831.82%-1.80M
-2319.78%-2.02M
-147.06%-168.00K
550.00%36.00K
195.65%66.00K
275.00%91.00K
19.05%-68.00K
94.59%-8.00K
---69.00K
---52.00K
---84.00K
---148.00K
Investing cash flow
Cash from non-current investing activities
Financing cash flow
Cash flow from continuous financing activities
3535.96%3.06M
-97.22%-142.00K
2428.57%5.22M
361.40%149.00K
-23.61%-89.00K
-323.53%-72.00K
-217.28%-224.00K
-118.81%-57.00K
-130.00%-72.00K
---17.00K
--191.00K
--303.00K
--240.00K
Net cash flow from debt Issuance/repayment
----
---142.00K
--40.00K
--102.00K
----
--0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
--0.00
--225.00K
--420.00K
--250.00K
Net cash flow from common stock issuance/repurchase
----
--0.00
--5.52M
----
----
----
----
----
----
----
----
----
----
Proceeds from issuance of warrants
--3.06M
----
----
----
----
----
----
----
----
----
----
----
----
Net cash flow from other financing activities
----
100.00%0.00
-55.36%-348.00K
182.46%47.00K
-23.61%-89.00K
-323.53%-72.00K
-558.82%-224.00K
51.28%-57.00K
-620.00%-72.00K
---17.00K
---34.00K
---117.00K
---10.00K
Net cash from non-recurrent financing activities
Net cash from financing activities
3535.96%3.06M
-97.22%-142.00K
2428.57%5.22M
361.40%149.00K
-23.61%-89.00K
-323.53%-72.00K
-217.28%-224.00K
-118.81%-57.00K
-130.00%-72.00K
---17.00K
--191.00K
--303.00K
--240.00K
Net cash flow
Beginning cash balance
1267.74%1.27M
3149.49%3.22M
-90.95%21.00K
-88.80%40.00K
-78.72%93.00K
-81.07%99.00K
-39.58%232.00K
116.36%357.00K
498.63%437.00K
--523.00K
--384.00K
--165.00K
--73.00K
Current period cash flow changes
4522.64%2.34M
-32316.67%-1.94M
2503.01%3.20M
84.80%-19.00K
33.75%-53.00K
93.02%-6.00K
-195.68%-133.00K
-157.08%-125.00K
-186.96%-80.00K
---86.00K
--139.00K
--219.00K
--92.00K
Ending cash balance
8940.00%3.62M
1267.74%1.27M
3149.49%3.22M
-90.95%21.00K
-88.80%40.00K
-78.72%93.00K
-81.07%99.00K
-39.58%232.00K
116.36%357.00K
--437.00K
--523.00K
--384.00K
--165.00K
Currency unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
--
--
--
--
--
--
--
--
